Clinical Trial Update: A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of topiramate in male patients with abdominal obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity | Phase 2 | Status: COMPLETED